HR-19024
- Generic Name
- HR-19024
A Study of HR19024 in Subjects With Advanced Solid Tumor
- First Posted Date
- 2022-07-19
- Last Posted Date
- 2025-03-20
- Lead Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Target Recruit Count
- 71
- Registration Number
- NCT05463432
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath